Search

Displaying results 5761 - 5770 of 10000 in total
  1. Drug

    NLX-P101

    go.drugbank.com/drugs/DB05924
    Experimental

    The gene is glutamic acid decarboxylase (GAD), whose product synthesizes the major inhibitory neurotransmitter in the brain, (gamma)-aminobutyric acid (GABA), and targets the subthalamic nucleus (STN), … NLX-P101, gene therapy is developed by Neurologix to treat Parkinson’s disease.

  2. Drug

    Cenacitinib

    go.drugbank.com/drugs/DB21735
    Investigational

    The usage of the INN stem '-citinib' in the name indicates that Cenacitinib is a Janus kinase inhibitor. … Cenacitinib is under investigation in clinical trial NCT05688852 (VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease).

  3. Drug

    Levoglucose

    go.drugbank.com/drugs/DB12970
    Investigational

    Levoglucose has been used in trials studying the diagnostic of Bowel Cleansing Prior to Colonoscopy.

  4. Drug

    Ulinastatin

    go.drugbank.com/drugs/DB12038
    Investigational

    Ulinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to Drug.

  5. Drug

    Thymidine monophosphate

    go.drugbank.com/drugs/DB01643
    Investigational

    A thymine nucleotide containing one phosphate group esterified to the deoxyribose moiety.

  6. Drug

    Iodamide

    go.drugbank.com/drugs/DB08948
    ApprovedWithdrawn

    Iodamide is a contrast medium molecule that is no longer marketed in the United States.

  7. Drug

    N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide

    go.drugbank.com/drugs/DB06942
    Experimental

    This compound belongs to the alpha amino acid amides. These are amide derivatives of alpha amino acids. This medication targets the protein prothrombin.

  8. Drug

    Human interferon omega-1

    go.drugbank.com/drugs/DB05472
    Investigational

    The biological activities of IFN-omega 1 and its physiological role are not known to date. … It occurs naturally in the human body and is currently being manufactured by Intarcia through genetic engineering.

  9. Drug

    BOS172722

    go.drugbank.com/drugs/DB15498
    Investigational

    [A187120] An in vivo study combined BOS172722 with [Paclitaxel] for the treatment of triple hormone receptor negative breast cancer, and demonstrated promising synergistic effects.[A187123] … The key role of Mps1 in the growth of cancer cells renders it an appealing target for cancer treatment, as its inhibition could lead to favorable effects.

  10. Drug

    GTP-506

    go.drugbank.com/drugs/DB17682
    Experimental

    the desired genetic correction. … GTP-506 is a gene therapy formed by two vectors, a nuclease vector targeting gene editing in the well-characterized PCSK9 gene locus and a therapeutic donor vector that inserts the OTC gene to provide